2020 Compensation actions with respect to Non-Employee Directors

The annual cash compensation payable to non-employee directors of Adamas Pharmaceuticals, Inc., or Adamas, to take effect immediately following the Adamas 2020 annual meeting, is as follows, payable quarterly in arrears:

Equity Compensation

Non-employee directors also receive an initial equity award upon commencement of service as a board member; thereafter, each non-employee director will receive an annual equity grant on the date of the Adamas annual meeting. The form of award in each case is a combination of a non-qualified stock option and a restricted stock unit. To take effect immediately following the Adamas 2020 annual meeting, the initial award is an option to purchase 20,000 shares of Adamas common stock and a restricted stock unit to acquire 10,000 shares of Adamas common stock, in each case vesting annually over three years of service. Each subsequent annual award is an option to purchase 10,000 shares of Adamas common stock and a restricted stock unit to acquire 5,000 shares of Adamas common stock, in each case vesting after one year of service. Upon the closing of a change of control, the vesting of all outstanding equity awards held by non-employee directors will accelerate in full.